King Hussein Cancer Center holds its 2nd Joint Conference Update on Genitourinary Malignancies 2013 in partnership with the AUB and MDACC

The two day conference will take place at Le Meridian Hotel in Amman during January 31- February 1st. The conference is organized by the King Hussein Cancer Center (KHCC) in collaboration with the American University of Beirut and the University of Texas MD Anderson Cancer Center (MDACC).

During the opening ceremony HRH Princess Ghida Talal welcomed the participants while stressing on the importance of such "Twinning" partnership that adds to the achievements of the King Hussein Cancer Center. She praised the progress achieved by Jordan, and the center in particular in the field of treatment of genitourinary malignancies.

Dr. Naim Farah, Chairman of the Conference and Chairman, Unit of Kidney surgery and Urinary Tract at King Hussein Cancer Center, said the first conference was held in Beirut as part of the cooperation between the three institutions associated with a twinning partnership as a result of the close cooperation that brings them together in many common areas such as: training, education, organization of joint scientific activities, exchange of experiences and joint research projects.

Dr. Farah added that this conference is held on annual basis in order to keep up with the latest findings of science in the diagnosis and treatment of the genitourinary malignancies.

He pointed out more than 150 doctors in the fields of surgery, clinical oncology, surgery genitourinary malignancies and therapeutic radiology, both Arab and international who are participating in the conference. Experts, consultants, researchers, and specialists from the United States of America, Lebanon and Jordan are expected to discuss the different aspects of genitourinary malignancies diagnosis, treatment and related approaches.

Dr. Faisal Al Badainh, Chairman of the Conference's Scientific Committee and Consultant Oncology in KHCC said that according to the National Cancer Registry in Jordan for the year 2009, around (206) new cases were diagnosed with urinary bladder cancer about (4.3%) out of all newly registered cancer cases. Malignant cancer of the urinary bladder accounted for (68.4%) of all urinary tract cancers in Jordan.
Dr. Al Badainh explained that bladder cancer is more frequent in males than in females as it is the 5th common cancer in males having affected (184) males (89.3%) while only (22) females were affected with bladder cancer each year with (10.7%). This means that the proportion of bladder cancer in males to females is (8.3:1) compared to (6.3:1) in 2008. He also added that bladder cancer incidence age for both sexes was 65 years.

On the other hand in (2009), there were (179) cases of prostate cancer accounting (3.7%) of all cancer cases. It ranked 6th among common cancers in males and accounted (7.9%) of male cancers. The prostate cancer increases with age. He confirmed that (75%) of prostate cancer cases occur at the age of ( 65) years and above, while the incidence age for diagnosis with prostate cancer reached (70) years.

According to Dr. Badainh the kidney and testicular cancers are less common than the bladder and prostate cancers.